Chronic rhinosinusitis is an inflammatory disease of the sinonasal mucosa with significant impact and limited treatment options. Chronic rhinosinusitis (CRS) poses an important public health problem and causes a large impact on individual quality of life. Studies of CRS have been limited by access to tissue, the complexity of the sinonasal physiology, a lack of available biomarkers, the absence of useful animal models, a paucity of cohorts with biological samples for analysis, and limited well-designed clinical trials or investigations of immune function. Therefore, novel strategies for identifying biological mechanisms underlying this disease are in great need. Using prospective samples from well characterized subjects, the investigators intend to profile the mucosa associated-bacteria in the nose and sinuses. In parallel, using sinus tissue from patients undergoing surgery, the site will interrogate the epithelium for mucosal immune function to understand host-microbe interaction. This study hypothesizes that the microbial profile of the sinuses initiates an immune responses which leads to chronic inflammation in susceptible people. This study would provide the first comprehensive data on what bacteria are present in the nose and sinus and could lead to important knowledge useful in sinonasal disease.
Study Type
OBSERVATIONAL
Enrollment
285
normals without allergy, those with perennial allergic rhinitis
Those with and without nasal polyps, and those with acute exacerbations
The University of Chicago
Hyde Park, Illinois, United States
Determining the distinct bacterial profiles with abundance of organisms using the Pyrosequencing Pipeline service
Time frame: At baseline until final values at 36 months.
Determining the distinct bacterial profiles with shift toward anaerobic bacteria using the Pyrosequencing Pipeline service
Time frame: At baseline until final values at 36 months.
Determining the distinct bacterial profiles with lower bacterial diversity using the Pyrosequencing Pipeline service
Time frame: At baseline until final values at 36 months.
the discovery of low frequency and novel organisms using the Pyrosequencing Pipeline service
Time frame: At baseline until final values at 36 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.